Cath labs or cardiac catheterization laboratories in hospitals conduct both diagnostic and therapeutic procedures. These laboratories are used to conduct normal procedures such as the monitoring of blood flow and heart pressure. Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system. One driver in market is growing focus on clinical trials. Vendors are using advanced technologies to develop innovative ablation catheters. They invest in R&D to develop cost-effective and efficient devices and lower manufacturing costs. Many of these devices are awaiting approval across different countries.
One of the primary drivers for this market is the rise in the adoption of minimally invasive procedures with improved medical imaging. Medical facilities across the world are shifting toward minimally invasive procedures, which involve the use of radiotherapy and imaging technologies and expand the treatment options for cardiac diseases such as atrial fibrillation. Through imaging, the anatomy of the heart can be studied, which helps the physician diagnose and conduct cardiac ablation procedure. For instance, fluoroscopy imaging is used for most of the complex atrial fibrillation procedures; fluoroscopy imaging modality is used to guide the catheter and improve the surgical outcome. These advantages of medical imaging are expected to propel growth in the global cardiac ablation market during the forecast period.
The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of cardiac ablation products. A number of factors such as success of microwave ablation procedure in clinical trials to treat atrial fibrillation, growing adoption of ablation in CVS disease treatment, and growing market penetration of ablation product manufacturers across developing countries are offering high growth opportunities for the players’ active in the Cardiac ablation market.
The global Cardiac Ablation market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Ablation market based on company, product type, end user and key regions.
This report studies the global market size of Cardiac Ablation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Ablation in these regions.
This research report categorizes the global Cardiac Ablation market by top players/brands, region, type and end user. This report also studies the global Cardiac Ablation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic
St. Jude Medical
AblaCor
Advanced Cardiac Therapeutics
AngioDynamics
Market size by Product
Irreversible Electroporation
HIFU
MRgFUS
Market size by End User
Cardiac Arrhythmia
Atrial Fibrillation
Tachycardia
Open Surgery
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cardiac Ablation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cardiac Ablation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cardiac Ablation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cardiac Ablation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cardiac Ablation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Ablation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Cardiac Ablation . Industry analysis & Market Report on Cardiac Ablation is a syndicated market report, published as Global Cardiac Ablation Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cardiac Ablation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.